readthroughSign in
CompanyCMPXNasdaqBoston, MA

Compass Therapeutics

Compass Therapeutics is a clinical-stage oncology company developing antibody-based therapeutics targeting angiogenesis, immune activation, and tumor-driven immunosuppression.

10-QNov 12Latest SEC filing
Nov 9Latest story